Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Active, not recruiting1
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

active_not_recruiting133%
completed133%
recruiting133%

Recent Activity

2 active trials
Showing 3 of 3
active_not_recruitingnot_applicable

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

NCT05198674
recruiting

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

NCT07174622
completednot_applicable

SPYRAL DYSTAL Renal Denervation Global Clinical Study

NCT04311086

Clinical Trials (3)

Showing 3 of 3 trials
NCT05198674Not Applicable

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Active Not Recruiting
NCT07174622

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

Recruiting
NCT04311086Not Applicable

SPYRAL DYSTAL Renal Denervation Global Clinical Study

Completed

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3